Tarfa Rahilla, Yu Sophie E, Ahmed Omar H, Moore John A, Bruña Ricardo, Velasquez Nathalia, Poplawsky Alexander J, Coffman Brian A, Lee Stella E
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, United States.
Front Allergy. 2023 Jan 9;3:1019265. doi: 10.3389/falgy.2022.1019265. eCollection 2022.
Currently, clinical assessment of olfaction is largely reliant on subjective methods that require patient participation. The objective method for measuring olfaction, using electroencephalogram (EEG) readings, can be supplemented with the improved temporal resolution of magnetoencephalography (MEG) for olfactory measurement that can delineate cortical and peripheral olfactory loss. MEG provides high temporal and spatial resolution which can enhance our understanding of central olfactory processing compared to using EEG alone.
To determine the feasibility of building an in-house portable olfactory stimulator paired with electrophysiological neuroimaging technique with MEG to assess olfaction in the clinical setting.
This proof-of-concept study utilized a paired MEG-olfactometer paradigm to assess olfaction in three normosmic participants. We used a two-channel olfactory stimulator to deliver odorants according to a programmed stimulus-rest paradigm. Two synthetic odorants: 2% phenethyl alcohol (rose) and 0.5% amyl acetate (banana) were delivered in increasing increments of time followed by periods of rest. Cortical activity was measured a 306-channel MEG system.
Primary outcome measure was the relative spectral power for each frequency band, which was contrasted between rest and olfactory stimulation.
Compared to rest, olfactory stimulation produced a 40% increase in relative alpha power within the olfactory cortex bilaterally with both odorants. A 25%-30% increase in relative alpha power occurred in the left orbitofrontal cortex and precentral gyrus with phenethyl alcohol stimulation but not amyl acetate.
In this proof-of-concept study, we demonstrate the feasibility of olfactory measurement an olfactometer-MEG paradigm. We found that odorant-specific cortical signatures can be identified using this paradigm, setting the basis for further investigation of this system as a prognostic tool for olfactory loss.
目前,嗅觉的临床评估在很大程度上依赖于需要患者参与的主观方法。使用脑电图(EEG)读数测量嗅觉的客观方法,可以通过改进的脑磁图(MEG)时间分辨率进行补充,用于嗅觉测量,这可以区分皮质性和周围性嗅觉丧失。与单独使用EEG相比,MEG提供了高时间和空间分辨率,能够增强我们对中枢嗅觉处理的理解。
确定构建一个内部便携式嗅觉刺激器与具有MEG的电生理神经成像技术配对,以在临床环境中评估嗅觉的可行性。
设计、设置和参与者:这项概念验证研究采用了配对的MEG - 嗅觉计范式来评估三名嗅觉正常参与者的嗅觉。我们使用双通道嗅觉刺激器根据编程的刺激 - 休息范式输送气味剂。两种合成气味剂:2%苯乙醇(玫瑰味)和0.5%乙酸戊酯(香蕉味)以递增的时间增量输送,随后是休息期。使用306通道MEG系统测量皮质活动。
主要结果测量指标是每个频段的相对频谱功率,在休息和嗅觉刺激之间进行对比。
与休息相比,两种气味剂在双侧嗅觉皮质内的相对α功率在嗅觉刺激时均增加了40%。苯乙醇刺激时,左眶额皮质和中央前回的相对α功率增加了25% - 30%,而乙酸戊酯刺激时未出现这种情况。
在这项概念验证研究中,我们证明了使用嗅觉计 - MEG范式进行嗅觉测量的可行性。我们发现使用该范式可以识别气味剂特异性的皮质特征,为进一步研究该系统作为嗅觉丧失的预后工具奠定了基础。